Olaf Wegener

Olaf Wegener is the Head of Research and Development at Siegfried Hameln GmbH. He joined Siegfried AG in 2015 and assumed the role of head of R&D at Siegfried’s sterile drug product site in Hameln, Germany. As the Head of Research and Development, he is responsible for overseeing the formulation development and analytical development of both small molecule and large molecule drug products. His role also encompasses process optimization and facilitating the transfer of projects from clients to Siegfried. With over 30 years of experience in the pharmaceutical industry, he has held various positions primarily in research and development, project management for strategic projects, and business development. His extensive expertise in these areas allows him to contribute valuable insights and drive innovation within the organization.